Back
OpGen 10K Form
Sell
25
OPGN
OpGen
Last Price:
0.48
Seasonality Move:
-6.68%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-14 | 10Q | OPGN/OpGen Quarterly |
| 2023-08-14 | 10Q | OPGN/OpGen Quarterly |
| 2023-05-15 | 10Q | OPGN/OpGen Quarterly |
| 2022-11-14 | 10Q | OPGN/OpGen Quarterly |
| 2022-08-12 | 10Q | OPGN/OpGen Quarterly |
| 2022-05-13 | 10Q | OPGN/OpGen Quarterly |
Receive OPGN News And Ratings
See the #1 stock for the next 7 days that we like better than OPGN
OPGN Financial Statistics
Sales & Book Value
| Annual Sales: | $2.61M |
|---|---|
| Cash Flow: | $-3.03M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.27 |
| Price / Book: | 1.76 |
Profitability
| EPS (TTM): | -6.51000 |
|---|---|
| Net Income (TTM): | $-26.16M |
| Gross Margin: | $-816.7K |
| Return on Equity: | -325.17% |
| Return on Assets: | -103.94% |
OpGen Earnings Forecast
Key OpGen Financial Ratios
- The Gross Profit Margin over the past 10 years for OPGN is -31.32%.
- The Selling, General & Administrative Expenses for OPGN have been equal to 507.38% of Gross Profit Margin.
- The Research & Development expenses have been 313.48% of Revenue.
- The Interest Expense is -8.73% of Operating Income.
- The Net Earning history of OPGN is -1,429.96% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 8 years.
OpGen Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | OPGN |
| CUSIP: | 68373L |
| Website: | opgen.com |
Debt
| Debt-to-Equity Ratio: | 3.44 |
|---|---|
| Current Ratio: | 0.28 |
| Quick Ratio: | 0.06 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |